Mixing reduces the number of daily injections
GLP-1 medications arent cheap
Recent evidence showed that Tirzepatide (TZP), a new drug including both Glucagon Like Peptide 1 (GLP-1) and Glucose-dependent Insulinotropic Polypeptide (GIP) receptor agonism, is effective in subjects with type 2 diabetes (T2D), lowering body weight, fat mass and glycated hemoglobin (HbA 1c ) also in obese or overweight adults without T2D
The vitamin is more quickly absorbed when administered in injection format, but this is also what makes it so effective for weight loss
GLP-1 receptor agonists are a class of medicines used mainly for type 2 diabetes and, in some cases, obesity or overweight with weight-related health problems
If a protocol lists doses in "units," contact the protocol author or institution for clarification on the mass equivalent